Home › Mutual Funds › Tata Mutual Fund › Tata India Pharma & Healthcare Fund Regular Rnvstmnt of Inc Dist cum Cap Wdrl
Latest NAV & returns of TATA ASSET MANAGEMENT LTD.

Tata India Pharma & Healthcare Fund Regular Rnvstmnt of Inc Dist cum Cap Wdrl

Add To Compare

previously known as Tata India Pharma & Healthcare Reg DR until

29.991 (0.181%)
NAV on April 29, 2026
Category Equity:
Sector - Healthcare
Investment StyleBox
Large Growth
Total Assets 1,229 cr
Turnover Ratio 11.18%
Expense Ratio 2.15%
Exit Load 0.25%if redeemed within
30 Days0.00%if redeemed after 30 Days
Returns
  • 1M: 5.48%
  • 1Y: 2.37%
  • 3M: 6.17%
  • 3Y: 22.05%
  • 6M: -3.54%
  • 5Y: 13.56%
Min Investment 5,000
ADDITIONAL INFO
Fund Manager Rajat Srivastava (Since over 1 year)
ISIN INF277K018A5
Fund Family Tata
P/E Ratio 38.31
P/B Ratio 5.88
Launch Date December 28, 2015
Benchmark Nifty Pharma TR INR
ASSET ALLOCATION
EQUITY DISTRIBUTION
RISK MEASURES (3 yrs)
vs Nifty Pharma TR INR

Alpha -1.69
Beta 0.97
R-Squared 93.94
Info Ratio -0.64
Tracking Err 4.17
Sortino 1.423
Sharpe 0.843
Std Dev 16.841
Risk -
SECTOR WEIGHTINGS (%)
Financial 0.63%
Industrial 0.0%
Technology 0.0%
Basic Materials 5.05%
Consumer Cyclical 0.0%
Utilities Services 0.0%
Healthcare Services 94.33%
Energy Services 0.00%
Communication Services 0.00%
Consumer Defensive 0.00%
Real Estate 0.00%
INVESTMENT OBJECTIVE

The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.

View Factsheet
-


Other plans of Tata India Pharma & Healthcare


Other Equity funds by Tata

Data Partner
Click here to visit AMC website and
read all scheme related documents Tata Fund